Ingrid Louise T.
- Country
- Denmark
- Department
- Department of Respiratory Medicine
Research Overview
- Evaluation of ARO-MMP7 Inhalation Solution in Idiopathic Pulmonary Fibrosis: A Phase 1/2a Clinical Trial in Healthy Subjects and Patients
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 323 of 607 partner sites.
Specializations
Pulmonary Fibrosis Research
The investigator specializes in various forms of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Their work encompasses evaluation of novel therapeutic approaches for managing lung function decline and associated symptoms.
- Interstitial lung disease management
- Fibrotic lung disease treatments
- Progressive fibrosing conditions
Respiratory Conditions
Focus areas include bronchiectasis, severe asthma, and chronic obstructive pulmonary disease (COPD). The investigator studies innovative treatments for these chronic respiratory conditions, particularly in cases resistant to conventional therapies.
- Airway disease management
- Exacerbation prevention
- Respiratory symptom control
Specialized Pulmonary Disorders
Research extends to pulmonary sarcoidosis, nontuberculous mycobacterial infections, and systemic sclerosis-associated interstitial lung disease. The investigator evaluates treatments for these complex pulmonary conditions.
- Granulomatous inflammation treatment
- Mycobacterial infection management
- Autoimmune-related lung conditions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.